Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.
2.

[Inhibitors of platelet glycoprotein IIb-IIIa in cardiology].

Obradović S, Gligić B, Djordjević D, Jovicić A, Romanović R, Ratković N, Dincić D, Orozović V, Nikolić G.

Vojnosanit Pregl. 2001 Jan-Feb;58(1):65-72. Review. Serbian. No abstract available.

PMID:
11419288
3.
4.

[Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].

Radke PW, Schunkert H.

Dtsch Med Wochenschr. 2006 Nov 24;131(47 Suppl 7):S204-7. Review. German. No abstract available.

PMID:
17109249
5.

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Roe MT, Sapp SK, Lincoff AM.

Cleve Clin J Med. 2000 Feb;67(2):131-40. Review.

PMID:
10680279
6.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
7.

[Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].

Auer J, Berent R, Lassnig E, Weber T, Maurer E, Eber B.

Herz. 2003 Aug;28(5):393-403. Review. German.

PMID:
12928738
8.

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Lincoff AM, Califf RM, Topol EJ.

J Am Coll Cardiol. 2000 Apr;35(5):1103-15. Review.

9.
12.

ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy.

Boden WE, Hoekstra J, Miller CD.

Am J Emerg Med. 2008 Feb;26(2):212-20. doi: 10.1016/j.ajem.2007.03.033. Review.

PMID:
18272105
13.

Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.

Ronner E, Dykun Y, van den Brand MJ, van der Wieken LR, Simoons ML.

Eur Heart J. 1998 Nov;19(11):1608-16. Review. No abstract available.

PMID:
9857912
14.

Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Bhatt DL, Topol EJ.

JAMA. 2000 Sep 27;284(12):1549-58. Review.

PMID:
11000650
15.

Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.

Gambhir DS, Mukhopadhyay S.

Indian Heart J. 2000 Sep-Oct;52(5):524-32. Review. No abstract available.

PMID:
11256774
16.

GP IIb/IIIa inhibitors in coronary artery disease management: what the latest trials tell us.

Chew DP, Moliterno DJ.

Cleve Clin J Med. 2001 Dec;68(12):1017-23. Review.

PMID:
11765119
18.

[Platelet glycoprotein IIB-IIIA receptor inhibitors in patients with ischemic heart disease].

Patti G, Fossati C, Manzoli A, D'Ambrosio A, Abbate A, Montesanti R, Di Sciascio G.

Clin Ter. 2000 Jul-Aug;151(4):301-6. Review. Italian.

PMID:
11107681
19.

[Impact of GP IIb/IIIa antagonists in interventional cardiology].

Scheller B, Hennen B, Böhm M, Nickenig G.

Dtsch Med Wochenschr. 2003 Feb 7;128(6):281-7. Review. German. No abstract available.

PMID:
12571800
20.

Glycoprotein IIb/IIIa receptor inhibition in interventional cardiology.

Gibson CM, Moynihan JL, Al-Mousa EN, Campsey M, Gandhi R, Murphy S, Mattson S, Ryan KA, Mesley R, Swanson J, Arshad MN, Marble SJ.

J Thromb Thrombolysis. 1999 Jun;7(3):287-302. Review. No abstract available.

PMID:
10375390

Supplemental Content

Support Center